| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 88.33B | 88.64B | 90.89B | 90.75B | 100.03B | 97.20B |
| Gross Profit | 16.03B | 16.42B | 17.06B | 17.71B | 20.08B | 17.43B |
| EBITDA | 10.63B | 12.22B | 11.91B | 12.71B | 18.71B | 20.23B |
| Net Income | 5.25B | 5.57B | 5.78B | 6.71B | 11.55B | 12.89B |
Balance Sheet | ||||||
| Total Assets | 71.81B | 73.09B | 70.07B | 70.86B | 71.12B | 69.41B |
| Cash, Cash Equivalents and Short-Term Investments | 5.80B | 5.89B | 6.32B | 6.04B | 7.59B | 10.59B |
| Total Debt | 25.13B | 32.29B | 25.65B | 26.73B | 23.52B | 25.53B |
| Total Liabilities | 56.02B | 56.84B | 53.33B | 53.54B | 51.32B | 55.14B |
| Stockholders Equity | 15.76B | 16.23B | 16.72B | 17.31B | 19.79B | 14.25B |
Cash Flow | ||||||
| Free Cash Flow | 4.52B | 4.76B | 6.21B | 5.08B | 9.34B | 10.81B |
| Operating Cash Flow | 8.36B | 8.45B | 10.12B | 10.24B | 14.10B | 15.01B |
| Investing Cash Flow | -4.32B | -4.74B | -217.00M | -7.13B | -7.47B | -3.82B |
| Financing Cash Flow | -3.16B | -4.14B | -6.85B | -5.53B | -11.19B | -6.82B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | $17.72B | 11.18 | 14.02% | 2.98% | 11.11% | 4.25% | |
76 Outperform | $20.33B | 20.83 | 36.71% | 1.02% | 1.13% | 2.62% | |
71 Outperform | $89.66B | 22.26 | 15.76% | 1.94% | 4.69% | 17.55% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
60 Neutral | $19.28B | 33.78 | 33.32% | 1.51% | -6.68% | 18.19% | |
58 Neutral | $84.09B | 24.20 | 33.03% | 6.55% | -2.59% | -9.78% | |
57 Neutral | $23.98B | 56.34 | 19.04% | ― | 3.63% | -11.81% |